rs587779688
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000090.4(COL3A1):c.636+5G>A variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000090.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL3A1 | ENST00000304636.9 | c.636+5G>A | splice_region_variant, intron_variant | Intron 7 of 50 | 1 | NM_000090.4 | ENSP00000304408.4 | |||
| COL3A1 | ENST00000450867.2 | c.636+5G>A | splice_region_variant, intron_variant | Intron 7 of 49 | 1 | ENSP00000415346.2 | ||||
| COL3A1 | ENST00000713745.1 | c.636+5G>A | splice_region_variant, intron_variant | Intron 7 of 48 | ENSP00000519049.1 | |||||
| COL3A1 | ENST00000713744.1 | c.636+5G>A | splice_region_variant, intron_variant | Intron 7 of 48 | ENSP00000519048.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, type 4 Pathogenic:3
This sequence change falls in intron 7 of the COL3A1 gene. It does not directly change the encoded amino acid sequence of the COL3A1 protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several individuals affected with Ehlers-Danlos syndrome, vascular type (PMID: 9399899, 12131463, 24399159). This variant is also described as IVS8+5G>A in the literature. ClinVar contains an entry for this variant (Variation ID: 101448). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that this variant results in exon skipping, leading to an in-frame deletion of exon 7, also reported as exon 8 in the literature (PMID: 9399899, 12131463). This splicing variant leads to a deletion of exon 7, which is expected to disrupt glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain that are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL3A1, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 24922459, 25758994) compared to the general population (ExAC). This suggests loss of these residues may also be pathogenic. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at